Q4 FY2024 · ended Dec 31, 2024 · Revenue $0, -100.0% YoY · Filed Apr 15, 2026
Profusa, Inc. (PFSA) files with the SEC under industry code 3841, Surgical & Medical Instruments & Apparatus. Free cash flow was -$2.7 million. As of Jun 30, 2026 it held $12.2 million in cash and investments and $100,000 in total debt.
Revenue
$0
-100.0% vs prior quarter
Net income
$-8.76M
-272.9% vs year-ago quarter
Operating cash flow
$-2.63M
-346.9% vs year-ago quarter
Free cash flow
$-2.71M
-4.8% vs prior quarter
EPS
$-151.80
+98.3% vs year-ago quarter
Dividend per share
None
Shares outstanding
605,647
-98.2% vs year-ago quarter
Net cash
$12.10M
Q2 FY2026
Operating margin
-1470.7%
Q3 FY2024
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- PFSA (Nasdaq), NVACW (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- New York, NY
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1859807
- Former names
- NorthView Acquisition Corp (until Jul 15, 2025)
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
All 151 Surgical & Medical Instruments & Apparatus companies
Key figures
Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.
| Line | Q2 FY2026 Jun 30, 2026 |
Q1 FY2026 Mar 31, 2026 |
Q4 FY2025 Dec 31, 2025 |
Q3 FY2025 Sep 30, 2025 |
Q2 FY2025 Jun 30, 2025 |
|---|---|---|---|---|---|
| Operating income | -$2.5M | -$4.0M | -$3.6M | -$21.7M | -$1.0M |
| Net income | -$8.8M | -$3.5M | -$8.6M | -$22.2M | -$2.3M |
| Diluted EPS | -$151.80 | -$2.05 | $0.25 | -$0.70 | -$9,100.78 |
| Operating cash flow | -$2.6M | -$2.6M | -$5.1M | -$10.0M | -$589,000 |
| Free cash flow | -$2.7M | -$2.6M | — | — | — |
| Total assets | $1.0M | $862,000 | $3.8M | $4.2M | $2.0M |
| Total liabilities | $28.2M | $29.1M | $30.4M | $38.2M | $23.1M |
| Stockholders' equity | -$27.1M | -$28.2M | -$26.7M | -$34.0M | -$124.2M |
| Cash and investments | $12.2M | $10.0M | $10.0M | $10.0M | — |
| Total debt | $100,000 | $200,000 | — | — | — |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Oct 15, 2026 | Oct 15, 2026 |
| 8-K |
Current report
Auditor change
|
Oct 9, 2026 | Oct 5, 2026 |
| 8-K |
Current report
Material agreement, New debt
|
Oct 5, 2026 | Oct 4, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Sep 21, 2026 | Sep 18, 2026 |
| 8-K |
Current report
Material agreement, New debt
|
Sep 16, 2026 | Sep 16, 2026 |
| 8-K |
Current report
Other events
|
Sep 15, 2026 | Sep 9, 2026 |
All 323 Profusa, Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.